Trastuzumab/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: Creating Related Articles subpage) |
mNo edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | <noinclude>{{subpages}}</noinclude> | ||
==Parent topics== | ==Parent topics== | ||
| Line 17: | Line 17: | ||
{{r|Breast cancer}} | {{r|Breast cancer}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|ErbB-2 receptor}} | |||
{{r|Humanized monoclonal antibody}} | |||
{{r|Monoclonal antibody}} | |||
{{r|Cell surface receptor}} | |||
Latest revision as of 11:00, 30 October 2024
- See also changes related to Trastuzumab, or pages that link to Trastuzumab or to this page or whose text contains "Trastuzumab".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Trastuzumab. Needs checking by a human.
- Antineoplastic agent [r]: Drug that prevents the development, maturation, or spread of neoplastic cells. [e]
- Breast cancer [r]: Cancer of the glandular breast tissue. [e]
- ErbB-2 receptor [r]: A cell surface protein-tyrosine kinase receptor that is found to be overexpressed in a significant number of adenocarcinomas. [e]
- Humanized monoclonal antibody [r]: "Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab." National Library of Medicine [e]
- Monoclonal antibody [r]: Highly specific antibodies produced in large quantity by the clones of a single hybrid cell formed in the laboratory by the fusion of a B cell with a tumor cell. [e]
- Cell surface receptor [r]: Proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell. [e]